Challenges in gastric, appendiceal and rectal NETs Leuven,
|
|
|
- Dustin Ford
- 10 years ago
- Views:
Transcription
1 Challenges in gastric, appendiceal and rectal NETs Leuven, Prof. Dr. Chris Verslype, Leuven Prof. Dr. Aurel Perren, Bern
2 Menue Challenges: 1. Gastric NET 2. Appendiceal NET 3. Rectal NET
3 SEER, U.S.A.
4 Incidence by stage: localized regional Lawrence et al, Endocrinol Metab Clin N Am
5 Gastric NET 23% of GI- NET (Austria) Type 1 Type 2 Type 3 NEC (Type 4) Background CAG MEN-1 sporadic sporadic Multifocality yes, stomach yes, stomach, duodenum etc. no no Surrounding mucosa LK-Meta if >1cm Atroph Hyperplastic Normal Normal 5% 30% 70% Allways?
6 Pathogenesis of gastric NET type 1 CAG associated
7
8
9 Gastric NET G1, type 1 BENIGN Corpus Antrum VMAT2 ICC
10 Pathogenesis of gastric NET type 1 MEN1/ZES associated MEN1-Keimbahnmutation ZES MEN1 germline mutation
11 Gastric NET G1, type 2 Corpus Antrum MEN1 and ZES
12 Gastric NET type 3 sporadic > Sporadic solitary ECLoma > EComa (serotonin producing) wdnet > Gastrinoma > Poorly differentiated (small cell) pdnec neuroendocrine Carcinoma
13 Treatment Endoscopic follow-up (1/yr) + endoscopic resection Risk of leaving lesions < 1 cm in place? Lesions > 1 cm: EUS and EMR (surgery) Delle Fave, Neuroendocrinology 2012
14 Treatment Local excision Delle Fave, Neuroendocrinology 2012
15 Treatment Treat as adenocarcinoma Delle Fave, Neuroendocrinology 2012
16 Conclusions: gastric NEN s Increasingly recognized due to expanding indications of upper endoscopy Management of gastric NEN s is driven by the subtype Type 1 and type 2: carefull endoscopic and pathological mapping place/extent of surgery not well defined Type 3: same approach as for gastric adenocarcinoma
17 Neuroendocrine neoplasms of the rectum Chris Verslype MD PhD U.Z. Leuven, Belgium
18
19 SEER, U.S.A.
20 SEER, U.S.A.
21 Epidemiology and prognosis Rapidly increasing incidence due to colonoscopy screening Asian > African > Caucasian Metastatic potential: < 1 cm: 2% 1-2 cm: 10-15% > 2 cm: 60-80% Mani and Modlin, J Am Coll Surg 1994
22 Epidemiology and prognosis localized disease: 90 % 5 year survival rate (5-YSR) regional disease: 62 % 5-YSR metastatic disease: 24 % 5-YSR Yao et al. JCO 2008
23 Clinical presentation Incidental finding Age: 56 No serotonin production
24 Rectal NEN Morphology Small round/yellow polyps Small pseudoglands, cell nests Frequently T1, cured after endoscopic resection Well differentiated (G1, MIB1<2%) Paul Komminoth Soga, J., Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature. J Exp Clin Cancer Res, (2): p
25 Rectal NEN Immunohistochemistry Positive for NE markers Synaptophysin, Chromogrannin A often negative Serotonin negative, GLP, PP positive (L-cells) Shunsuke Tsukamoto, J. Int J Colorectal Dis p
26 Rectal NEN Differential diagnosis No problem Think of it Immunohistochemistry in small samples of well differentiated infiltrating tumor with artefacts!
27 Staging Endoscopic ultrasound Lesions > T1 MRI
28
29 Weinstock et al. Neuroendocrinology 2013
30 Weinstock et al. Neuroendocrinology 2013
31 Treatment NEN < 1 cm : Endoscopic resection (EMR, ESD) In case of T1a lesion, and low grade (G1), no invasion of muscularis mucosae or lymphovascular invasion: no follow-up
32 Treatment NEN 1-2 cm : G2, lymphatic invasion: surgery probably the best option No invasive/ aggressive features: endoscopic resection
33 Treatment NEN > 2 cm: Treatment as rectal adenocarcinoma
34 Conclusions Increasing incidcence Size/ invasion/ grade: determinants of prognosis Lesions between 1-2 cm: challenge (endosocpy, minimal invasive surgery ) Multidisciplinary discussion
35 Rectal NET SEER Japan LN-metastasis < 5 mm n.a. 3.7 % < 10 mm 3 % 9.7 % > mm % 27.6 % > 20 mm % n.a. <1cm, L0, pt1: No metastases! In Austria: 60% <1cm, 20% 1-2cm 35
36 Colonic NEN Different tumors! rare Frequently malignant Frequently G3 (NEC) or mixed (MANEC) Niederle M: ERC,
37 Appendix NET 50-77% of appendiceal neoplasms 19% of all NET Inzidence 0.15/ /Jahr 1/300 appendectomies More frequently in women (2:1)
38 Appendix NET prognosis > local disease: % 5 year survival rate (5-YSR) > regional disease: % 5-YSR > metastatic disease: 12-28% 5-YSR > overall % 5-YSR
39 Appendix NET prognosis <1cm: (allmost) never metastases >2cm: Relevantes Metastase-Risiko (21-44%) Moertel 1987: 150 patients 127 <2cm no LN meta 3/14 2-3cm LN meta (21%) 4/9 >3cm LN meta (44%) Bamboat Patienten <2cm: no Meta Anderson Patienten <2cm: 2 Meta (1.3%) Syracuse Patienten <1cm: 2 Meta (2.1%)
40 Staging > ONLY for tumours > 1cm > Imaging: CT or MRI SRS (tumours > 2 cm) > Blood tests: Chromogranin A (M+)
41 TNM-Appendix UICC 2010: T1a (<1cm), T1b 1-2cm ENETS T1 (<1cm) T2 (2 4cm) T3 (>4cm, Invasion Ileum) identical? T2 (<2cm <3mm Mesoappendix) T3 (> 2cm, > 3mm Mesoappendix) T4 (Invasion Peritoneum andere Organe) T4 (Invasion Peritoneum andere Organe)
42
43 65-85% of appendiceal NEN 100% cure No follow-up No additional work-up
44 <10% of appendiceal NEN M+ in 25-40% Radical resection Long term follow-up
45 5-25% of appendiceal NEN M+ in 0-10% Type of resection? Long term follow-up?
46 B01_19800
47 B01_19800_Mesenteriolon
48 LKmeta in eins von 15
49 699 pts < 20 years T >2 cm: 4% Invasion mesoappendix: 30,5% Further resection: 11,6% Recurrence/death: 0 Kim et al. 2014
50 Treatment NEN < 1 cm (ENETS stage 1, UICC 1a): Appendectomy when location at the base of the appendix, meso-appendix > 3 mm: discuss right hemicolectomy (very rare...)
51 Treatment NEN > 2 cm (ENETS stage 3, UICC 2): Right hemicolectomy
52 Treatment NEN 1-2 cm (ENETS stage 2, UICC 1b): Base of the appendix, R1 resection, Young age, Meso-appendix > 3 mm: Right hemicolectomy Additionnal criteria: G2 grade, angioinvasion?
53 Goblet cell carcinoid/carcinoma A subset of the MANEC type RARE! Eminence -based medecine
54 Goblet cell carcinoid/carcinoma TNM staging is the same as for adenocarcinoma of the appendix Treatment is right hemicolectomy, rapidly after diagnostic appendectomy Surgery of liver metastases? No data.. Chemotherapy: 5-FU based (FOLFOX), 50% SD for 8-12 months.
55 Questions
Thursday, November 3, 2005
Thursday, November 3, 2005 8:30-10:30 a. m. Gastric Tumors, Session 1 Chairman: P. Ruszniewski, Clichy, France 9:00-9:30 a. m. Working Group Sessions Pathology and Genetics Group leaders: G. Rindi, Parma,
Günter Klöppel Dept. of Pathology Consultation Center for Pancreatic and Endocrine tumors Technische Universität München
Günter Klöppel Dept. of Pathology Consultation Center for Pancreatic and Endocrine tumors Technische Universität München Incidental 1.5 cm tumor in a 45-year old man: Most probable diagnosis - Pan NEN.
EMR Can anyone do this?
EMR Can anyone do this? Norio Fukami, MD University of Colorado Piecemeal resection? 1 Endoscopic mucosal resection (EMR) and Endoscopic submucosal dissection (ESD) Endoscopic removal of premalignant or
Gastrointestinal and pancreatic neuroendocrine tumours. Dr. med. Henrik Csaba Horváth
Gastrointestinal and pancreatic neuroendocrine tumours Dr. med. Henrik Csaba Horváth What is the definition of neuroendocrine tumours? Neuroendocrine tumours are neoplastic lesions, composed either by
PROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
Aktualne reguły leczenia nowotworów neuroendokrynnych przewodu pokarmowego
Aktualne reguły leczenia nowotworów neuroendokrynnych przewodu pokarmowego Current treatment options for neuroendocrine GI tumors Archil Aladashvili, GE Current treatment options for neuroendocrine GI
Learning Luncheon 7: Endoscopic Mucosal Resection: When, Where and How?
Endoscopic Mucosal Resection (EMR): When, Where, and Charles J. Lightdale, MD Columbia University New York, NY Endoscopic Mucosal Resection (EMR) EMR developed for removal of sessile or flat neoplasms
Colorectal cancer. A guide for journalists on colorectal cancer and its treatment
Colorectal cancer A guide for journalists on colorectal cancer and its treatment Contents Contents 2 3 Section 1: Colorectal cancer 4 i. What is colorectal cancer? 4 ii. Causes and risk factors 4 iii.
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Hosts. New Methods for Treating Colorectal Cancer
Hosts Anees Chagpar MD Associate Professor of Surgical Oncology Francine MD Professor of Medical Oncology New Methods for Treating Colorectal Cancer Guest Expert: Scott, MD Associate Professor in the Department
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS
Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures
Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD
Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD AATS Toronto April 26, 2014 Lorenzo Ferri MD PhD David S. Mulder Chair in Surgery Associate Professor of Surgery and Oncology Disclosures Olympus
How to report Upper GI EMR/ESD specimens
Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early
The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).
INTRODUCTION This book has been prepared for people with bowel cancer, their families and friends. The first section is for people with bowel cancer, and is intended to help you understand what bowel cancer
Primary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
OBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
Directly Coded Summary Stage Is Back
Directly Coded Summary Stage Is Back Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry June 30, 2015 1 Outline What is SEER Summary Stage 2000 (SS2000)? Summary Stage Housekeeping
Case of the. Month October, 2012
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
How to treat early gastric cancer. Surgery
How to treat early gastric cancer Surgery Mark I. van Berge Henegouwen Department of Surgery, AMC, Amsterdam Director upper GI surgical unit Academic Medical Center Upper GI surgery at AMC 100 oesophagectomies
Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16
Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16 Billing Guideline Background Health First administers benefit packages with full coverage
ESD for colorectal lesions I am in favour. Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy
ESD for colorectal lesions I am in favour Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy Surgery for early colonic lesions 51 pts referred for lap colectomy
There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
Neuroendocrine Tumors: Classification and Pathological Categorization
Neuroendocrine Tumors: Classification and Pathological Categorization M. Anlauf, G. Klöppel and P. Grabowski Institut für Pathologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel Michaelisstr.
Colonoscopy Data Collection Form
Identifier: Sociodemographic Information Type: Zip Code: Gender: Height: (inches) Race: Ethnicity Inpatient Outpatient Male Female Birth Date: Weight: (pounds) American Indian (Native American) or Alaska
General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and
Neuroendocrine Tumors
Neuroendocrine Tumors Neuroendocrine tumors arise from cells that release a hormone in response to a signal from the nervous system. Neuro refers to the nervous system. Endocrine refers to the hormones.
Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.
This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:
The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
A912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
Neoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
and Helicobacter pylori
Family Practice Oncology Network Upper Gastrointestinal Cancer (Suspected) Part 2 External Review Effective Date: TBD SCOPE: Part 2 of this guideline outlines recommendations for the prevention, screening,
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
Outline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
Pancreatic Cancer. The Killer that must be discovered early. Dr Alfred Kow Wei Chieh
Pancreatic Cancer The Killer that must be discovered early 27 th June 2015 Dr Alfred Kow Wei Chieh Consultant Department of Surgery Division of HPB Surgery & Liver Transplantation & Assistant Dean (Education)
Rectal Cancer. To Radiate or not to radiate? Q: Should rectal cancer RT/CRT decisions be based solely on stage? 11/09/2014
Rectal Cancer To Radiate or not to radiate?? Dr. Corinne Doll Radiation Oncologist Tom Baker Cancer Centre Calgary, Alberta Q: Should rectal cancer RT/CRT decisions be based solely on stage? 1 Q: Can RT/CRT
The digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies
The digestive system Medicine and technology Normal structure and function Diagnostic methods Example diseases and therapies The digestive system An overview (1) Oesophagus Liver (hepar) Biliary system
Non-Functioning Pancreatic Neuroendocrine Tumours
Non-Functioning Pancreatic Neuroendocrine Tumours NET Patient Foundation Non-Functioning Pancreatic Neuroendocrine Tumours This booklet is intended to provide patients and their carers with information
Endoscopic Resection for Barrett s Esophagus and Early Cancer 2014 Masters of Minimally Invasive Surgery
Endoscopic Resection for Barrett s Esophagus and Early Cancer 2014 Masters of Minimally Invasive Surgery Matthew Hartwig, M.D. Duke Cancer Institute Case Presentation: Patient ER 51 y/o man with schizophrenia
Endoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R.
Controversies in Gastroenterology Endoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R. Raúl Cañadas Garrido, MD. 1 1 Internist-Gastroenterologist.
How CanCer becomes critical in the claims
How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
DELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
Captivator EMR Device
Device Clinical Article and Abstract Summary Endoscopic Mucosal Bergman et al: EMR Training Tips Bergman et al: EMR Learning Curve ASGE: EMR & ESD Guidelines Bergman et al: Captivator EMR vs Cook Duette
Advances in Differentiated Thyroid Cancer
Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification
Together, The Strength
DECATUR County Indiana Together, The Strength to Fight Cancer Barbara Taylor, MD Cancer Committee Chairperson Rahul Dewan, DO Radiation Oncology Cancer Liasion Jaime Ayon, MD Medical Oncology/ Hematology
Understanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
High-Grade Neuroendocrine Tumours. NET Patient Foundation
High-Grade Neuroendocrine Tumours NET Patient Foundation High-Grade Neuroendocrine Tumours (NETs) This booklet is intended to provide patients and their carers with information relating to the diagnosis,
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL HEPATOCELLULAR CARCINOMA GI Site Group Hepatocellular Carcinoma Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION
Something Old, Something New.
Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan
NEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
National Program of Cancer Registries Education and Training Series. How to Collect High Quality Cancer Surveillance Data
National Program of Cancer Registries Education and Training Series How to Collect High Quality Cancer Surveillance Data 1 NAACCR Administers NPCR-Education Contract for the Centers for Disease Control
Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA
Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically
Lung cancer is not just one disease. There are two main types of lung cancer:
1. What is lung cancer? 2. How common is lung cancer? 3. What are the risk factors for lung cancer? 4. What are the signs and symptoms of lung cancer? 5. How is lung cancer diagnosed? 6. What are the available
Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
Cancer Screening and Early Detection Guidelines
Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical
Management of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives. Dominique ELIAS
Management of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives Dominique ELIAS Declaration of interest BOARDS Congress and teaching 0 Merck 0 Ipsen Novartis Sanofi Trials The peritoneum
Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center
Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary
Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth
Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes Dr. med. Henrik Csaba Horváth Why is risk stratification for colorectal cancer (CRC)
LIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
SMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Gastrointestinal Stromal Tumor (GIST) What is cancer?
Gastrointestinal Stromal Tumor (GIST) What is cancer? The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly way. During the early years
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
YOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
Barrett s oesophagus: specimen handling and reporting
Barrett s oesophagus: specimen handling and reporting Professor Neil A Shepherd Gloucester and Cheltenham, UK The role of the pathologist in Barrett s oesophagus 1. Diagnosis 2. Typing 3. Assessing response
Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation
Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Yan Xing, MD, PhD, Ryaz B. Chagpar, MD, MS, Y Nancy You MD, MHSc, Yi Ju Chiang, MSPH, Barry W. Feig, MD, George
Ching-Yao Yang, Yu-Wen Tien
Ching-Yao Yang, Yu-Wen Tien Division of General Surgery, Department of Surgery, National Taiwan University Hospital Oct-30-2010 Pancreatic NET have poorer prognosis when presence of liver metastases at
Frequently Asked Questions (FAQ s)
Frequently Asked Questions (FAQ s) The TNM Project Committee receives questions concerning the use of TNM and how to interpret rules in specific situations. Some questions and answers are listed below
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.
There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers
Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer
Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:242 250 MORTALITY Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer David Wesley, MD; Hugh
Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College
Colorectal Cancer Care A Cancer Care Map for Patients
Colorectal Cancer Care A Cancer Care Map for Patients Understanding the process of care that a patient goes through in the diagnosis and treatment of colorectal cancer in BC. Colorectal Cancer Care Map
Frequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 [email protected] Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative where and when? William Allum
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative where and when? William Allum Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY H N SN. WEDGE
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens